Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immatics NV (NQ: IMTX )

9.770 -0.080 (-0.81%)
Streaming Delayed Price Updated: 2:02 PM EDT, May 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 168,175
Open 9.840
Bid (Size) 9.740 (4)
Ask (Size) 9.810 (1)
Prev. Close 9.850
Today's Range 9.590 - 10.10
52wk Range 5.900 - 13.60
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Recap: Immatics Q1 Earnings
 
Via Benzinga
Immatics Announces First Quarter 2023 Financial Results and Business Update
From https://immatics.com/
Via GlobeNewswire

Performance

YTD
+14.00%
+14.00%
1 Month
+33.47%
+33.47%
3 Month
+12.56%
+12.56%
6 Month
-3.74%
-3.74%
1 Year
+34.39%
+34.39%

More News

Read More
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
What's Going On With Immatics Shares Today
Via Benzinga
Why Immatics Stock Is Soaring Today
Via The Motley Fool
Immatics Immunotherapy Candidate Shows Confirmed Responses In Different Solid Cancers
Via Benzinga
US Stocks Down; Chegg Crashes After Removing Guidance On ChatGPT Concerns
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Immatics Reports Interim Clinical Data from Ongoing Phase 1b Cohort A Monotherapy with ACTengine® IMA203 TCR-T Targeting PRAME
From https://immatics.com/
Via GlobeNewswire
Bristol-Myers Squibb's Breyanzi Aces Two Lymphoma Studies On Overall Response Rate Endpoint, Plus New Collaboration
Via Benzinga
Immatics Announces First Bristol Myers Squibb Opt-in of TCR-T Candidate from Ongoing Multi-target Strategic Collaboration
From https://immatics.com/
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
Via Benzinga
Immatics Announces Full Year 2022 Financial Results and Corporate Update
From https://immatics.com/
Via GlobeNewswire
First Majestic Silver, Immatics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Immatics Announces Third Quarter 2022 Financial Results and Business Update
From https://immatics.com/
Via GlobeNewswire
Alphatec Holdings, Immatics And Some Other Big Stocks Moving Higher On Monday
Via Benzinga
Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday
Via Benzinga
Why Is Nutex Health (NUTX) Stock on the Move Today?
Via InvestorPlace
Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Ford Stock Slumps 7% on Analyst Downgrade
Via InvestorPlace
Why Is Immatics (IMTX) Stock Up 7% Today?
Via InvestorPlace
Immatics Announces $110 Million Underwritten Offering of Ordinary Shares
From https://immatics.com/
Via GlobeNewswire
Immatics Reports Interim Clinical Data Update on ACTengine® IMA203 TCR-T Monotherapy Targeting PRAME
From https://immatics.com/
Via GlobeNewswire
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.